Are you Dr. Ruprecht?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 27 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
44 Binney St
Dana-Farber Cancer Institute, Jfb 809
Boston, MA 02115Phone+1 617-632-3719Fax+1 617-632-3112
Summary
- Dr. Ruth Ruprecht, MD is an oncologist in Boston, Massachusetts. She is currently licensed to practice medicine in Massachusetts and California. She is affiliated with Dana-Farber Cancer Institute and is a Professor of Medicine at Dana-Farber Cancer Institute.
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1982 - 1983
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1980 - 1982
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1977 - 1980
- University of Miami Leonard M. Miller School of MedicineClass of 1977
Certifications & Licensure
- CA State Medical License 1978 - 2018
- MA State Medical License 1984 - 2015
Publications & Presentations
PubMed
- 717 citationsHuman neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection.Timothy W. Baba, Vladimir Liska, Regina Hofmann-Lehmann, Josef Vlasak, Weidong Xu
Nature Medicine. 2000-02-01 - 7 citationsLive attenuated Rev-independent Nef¯SIV enhances acquisition of heterologous SIVsmE660 in acutely vaccinated rhesus macaques.Siddappa N. Byrareddy, Mila Ayash-Rashkovsky, Victor G. Kramer, Sandra J. Lee, Mick Correll
Plos One. 2013-09-30 - 88 citationsPentoxifylline (trental) decreases the replication of the human immunodeficiency virus type 1 in human peripheral blood mononuclear cells and in cultured T cellsFatemeh Fazely, Bruce J. Dezube, Judy Allen-Ryan, Arthur B. Pardee, Ruth M. Ruprecht
Blood. 1991-04-15
Press Mentions
- Adjuvanted HIV-1 Vaccine Promotes Antibody-Dependent Phagocytic Responses and Protects Against Heterologous SHIV ChallengeSeptember 3rd, 2020
- Mymetics Receives Funding from NIH for Novel HIV Vaccine StudyApril 29th, 2019
- Evidence for Persistence of the SHIV Reservoir Early After MHC Haploidentical Hematopoietic Stem Cell TransplantationOctober 25th, 2018
- Join now to see all
Grant Support
- Infant Immunoprophylaxis Against A Primate LentivirusNational Institute Of Allergy And Infectious Diseases2003–2012
- Neutralizing Antibody Coverage For CTL Vaccines (Project 2)National Center For Research Resources2010–2011
- Small Animal ContainmentNational Institute Of Allergy And Infectious Diseases2009–2011
- HIV-1 Microglial Tropism And NeurovirulenceNational Center For Research Resources2009–2011
- Molecular BiologyNational Institute Of Allergy And Infectious Diseases2008–2011
- Administrative CoreNational Institute Of Allergy And Infectious Diseases2008–2011
- Vaccination Against Mucosal HIV Clade C TransmissionNational Institute Of Allergy And Infectious Diseases2007–2011
- Harnessing Humoral Immunity Against HIV Clade CNational Institute Of Allergy And Infectious Diseases2007–2011
- SHIV Transmission Through Oral VS Other MucosaeNational Center For Research Resources2005–2011
- Attenuated Recombinant Listeria As Oral AIDS VaccineNational Center For Research Resources2004–2011
- Molecular Evolution Of Multiply Deleted SIV In VivoNational Center For Research Resources2003–2011
- Infant Immunoprophylaxis Against A Primate LentivirusNational Center For Research Resources2003–2011
- Attenuated Listeria Vectors As An AIDS Vaccine In MacaquesNational Institute Of Allergy And Infectious Diseases2009
- HIV-1 ENV Microglial Tropism And NeurovirulenceNational Institute Of Neurological Disorders And Stroke2008–2009
- Vaccination Against Intrapartum HIV-1 Clade C TransmissionNational Center For Research Resources2003–2009
- Mechanisms Of Oral SIV TransmissionNational Center For Research Resources2003–2008
- Molecular Evolution Of Multiply Deleted SIV In VivoNational Center For Research Resources1999–2008
- Administrative SupportNational Institute Of Allergy And Infectious Diseases2007
- SHIV Transmission Through Oral Versus Other MucosaeNational Institute Of Dental &Craniofacial Research2004–2007
- HIV VaccinesNational Institute Of Allergy And Infectious Diseases2006
- Vaccination Against Intrapartum HIV Clade C TransmissionNational Institute Of Allergy And Infectious Diseases2000–2006
- Dynamics Of SHIV Clade C And S Mansoni CoinfectionNational Institute Of Allergy And Infectious Diseases2005
- Vaccination Against Intrapartum HIV1 Cladec TransmissionNational Center For Research Resources2004
- Molecular Evolution Of Multiple Deleted SIV In VivoNational Center For Research Resources2004
- Attenuated Recombinant Listeria As Oral AIDS VaccineNational Institute Of Allergy And Infectious Diseases2003
- Towards An Oral AIDS VaccineNational Center For Research Resources2003
- Mechanisms Of Oral SIV TransmissionNational Institute Of Dental &Craniofacial Research1999–2003
- Fetal Immunoprophylaxis Against Primate LentivirusNational Center For Research Resources1999–2003
- Passive Immunization With Synergistic Human MabsNational Institute Of Allergy And Infectious Diseases2000–2002
- Core--Animal Biohazard FacilityNational Institute Of Allergy And Infectious Diseases1999–2002
- REV Independent Sivmac239 Infection In Newborn MacaquesNational Center For Research Resources1999–2002
- Immunotherapy Of Congenital SIV InfectionNational Center For Research Resources1999–2002
- Lentivirus Infection Of Neonatal Dendritic CellsNational Institute Of Allergy And Infectious Diseases1998–2002
- Vaccination Against Mucosal SIV Infection In NeonatesNational Center For Research Resources1997–2002
- Fetal Immunoprophylaxis Against A Primate LentivirusNational Institute Of Allergy And Infectious Diseases1997–2001
- SIV &Hiv Pathogenesis During OntogenyNational Center For Research Resources2000
- Vaccination Against Intrapartum HIV Clade C TransmissionNational Institute Of Allergy And Infectious Diseases1999
- Core--Animal BiohazardNational Institute Of Allergy And Infectious Diseases1996–1998
- SIV And HIV Pathogenesis During OntogenyNational Institute Of Allergy And Infectious Diseases1995–1998
- Vaccination Against Mucosal SIV Infection In NeonatesNational Institute Of Allergy And Infectious Diseases1994–1998
- Rev-Independent Sivmac 239 Infection In Newborn MacaquesNational Institute Of Allergy And Infectious Diseases1997
- Immunotherapy Of Congenital SIV Infection:VaccineNational Center For Research Resources1997
- Fetal Immunoprophylaxis Against A LentivirusNational Institute Of Allergy And Infectious Diseases1994–1996
- SIV Pathogenesis During OntogenyNational Institute Of Allergy And Infectious Diseases1991–1994
- Isolation And Characterization Of Rodent LentivirusesNational Institute Of Allergy And Infectious Diseases1990–1992
- Biological Response Modifiers As Therapies For AIDSNational Institute Of Allergy And Infectious Diseases1987–1991
Professional Memberships
- Member